SG Americas Securities
WVE icon

SG Americas Securities’s Wave Life Sciences WVE Stock Holding History

SG Americas Securities’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
43,368
+22,445
+107% +$149K ﹤0.01% 2686
2026
Q1 		$152K Sell
20,923
-46,108
-69% -$601K ﹤0.01% 2769
2025
Q4 		$1.14M Buy
+67,031
New +$681K ﹤0.01% 1907
2025
Q1 		– Sell
-53,419
Closed -$661K – 3794
2024
Q4 		$661K Buy
53,419
+16,856
+46% +$225K ﹤0.01% 1113
2024
Q3 		$300K Sell
36,563
-97,264
-73% -$581K ﹤0.01% 2148
2024
Q2 		$668K Buy
+133,827
New +$763K ﹤0.01% 1524
2024
Q1 		– Sell
-34,562
Closed -$175K – 3496
2023
Q4 		$175K Buy
34,562
+8,694
+34% +$46.5K ﹤0.01% 2291
2023
Q3 		$149K Buy
+25,868
New +$118K ﹤0.01% 2504
2022
Q2 		– Sell
-486,048
Closed -$972K – 3642
2022
Q1 		$972K Sell
486,048
-330,690
-40% -$810K 0.01% 1454
2021
Q4 		$2.56M Buy
816,738
+707,924
+651% +$2.94M 0.01% 898
2021
Q3 		$533K Buy
+108,814
New +$660K ﹤0.01% 2438
2020
Q3 		– Sell
-11,137
Closed -$116K – 3534
2020
Q2 		$116K Buy
+11,137
New +$105K ﹤0.01% 3281
2019
Q2 		– Sell
-3,602
Closed -$140K – 3471
2019
Q1 		$140K Buy
+3,602
New +$146K ﹤0.01% 2832

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

SG Americas Securities's WVE Position: Q2 2026 in Review

SG Americas Securities increased its Wave Life Sciences (WVE) stake by 107% in Q2 2026, buying an estimated $149K and bringing the position to 43,368 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #2686.

SG Americas Securities first reported a position in WVE in Q1 2019 and has held it in 13 quarters since. The position peaked at $2.56M in Q4 2021. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • SG Americas Securities held 43,368 shares of Wave Life Sciences worth $252K as of Q2 2026.
  • SG Americas Securities bought 22,445 Wave Life Sciences shares in Q2 2026, an estimated $149K.
  • Wave Life Sciences made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2686 holding.
  • SG Americas Securities first reported a position in Wave Life Sciences in Q1 2019 and has held it in 13 quarters since.
  • SG Americas Securities's Wave Life Sciences position peaked at $2.56M in Q4 2021.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.